Why Is Regeneron Pharmaceuticals Stock Trading Lower Today? - Regeneron Pharmaceuticals ( NASDAQ:REGN )
On Thursday, Regeneron Pharmaceuticals Inc REGN reported third-quarter adjusted EPS of $12.46, up 8% year-over-year, beating the consensus of $11.69. The company reported sales of $3.72 billion, up 11%, beating the consensus of $3.67 billion. "Regeneron had a strong third quarter marked by 11% ...
https://www.benzinga.com/general/biotech/24/10/41660999/why-is-regeneron-pharmaceuticals-stock-trading-lower-today